Literature DB >> 18240339

Refractory celiac disease and sprue-like intestinal disease.

Hugh James Freeman1.   

Abstract

Celiac disease is a gluten-dependent small intestinal mucosal disorder that causes malabsorption, often with diarrhea and weight loss. Diagnosis is based on detection of typical biopsy changes in the proximal small bowel, followed by evidence for an unequivocal response to a gluten-free diet. Refractoriness in celiac disease may be due to poor diet compliance, sometimes intentional, or consumption of ubiquitious sources of gluten. Alternatively, the original diagnosis may not be correct (eg., duodenal Crohn's disease), or a second cause for symptoms may be present (eg., collagenous colitis, functional bowel disorder). In some with recurrent symptoms, a complication may be present (eg., collagenous sprue, small bowel carcinoma, lymphoma). In some, a response to a gluten-free diet can not be unequivocally defined, and more precise historical terms have been used including "sprue-like intestinal disease" or "unclassified sprue". Although a "wastebasket diagnosis", these likely represent a heterogeneous group, and some, but not all, may develop lymphoma. Precise definition will be critical in the future as an array of new treatments, including biological agents, may emerge.

Entities:  

Mesh:

Year:  2008        PMID: 18240339      PMCID: PMC2687049          DOI: 10.3748/wjg.14.828

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

1.  Collagenous colitis as the presenting feature of biopsy-defined celiac disease.

Authors:  Hugh James Freeman
Journal:  J Clin Gastroenterol       Date:  2004-09       Impact factor: 3.062

2.  Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.

Authors:  Mark J Bishton; Andrew P Haynes
Journal:  Br J Haematol       Date:  2006-11-20       Impact factor: 6.998

3.  Cladribine therapy in refractory celiac disease with aberrant T cells.

Authors:  Abdulbaqi Al-Toma; Marije S Goerres; Jos W R Meijer; B Mary E von Blomberg; Peter J Wahab; Jo A M Kerckhaert; Chris J J Mulder
Journal:  Clin Gastroenterol Hepatol       Date:  2006-09-18       Impact factor: 11.382

4.  Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma.

Authors:  Santiago Vivas; José María Ruiz de Morales; Fernando Ramos; Dimas Suárez-Vilela
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

5.  The MYO9B gene is a strong risk factor for developing refractory celiac disease.

Authors:  Victorien M Wolters; Wieke H M Verbeek; Alexandra Zhernakova; Charlotte Onland-Moret; Marco W J Schreurs; Alienke J Monsuur; Willem Verduijn; Cisca Wijmenga; Chris J J Mulder
Journal:  Clin Gastroenterol Hepatol       Date:  2007-10-29       Impact factor: 11.382

6.  Endoscopic and histological findings in the duodenum of adults with celiac disease before and after changing to a gluten-free diet: a 2-year prospective study.

Authors:  A Tursi; G Brandimarte; G M Giorgetti; W Elisei; C D Inchingolo; E Monardo; F Aiello
Journal:  Endoscopy       Date:  2006-07       Impact factor: 10.093

7.  Sprue by any other name.

Authors:  C E Rubin; S Eidelman; W M Weinstein
Journal:  Gastroenterology       Date:  1970-03       Impact factor: 22.682

8.  Abnormal intestinal intraepithelial lymphocytes in refractory sprue.

Authors:  C Cellier; N Patey; L Mauvieux; B Jabri; E Delabesse; J P Cervoni; M L Burtin; D Guy-Grand; Y Bouhnik; R Modigliani; J P Barbier; E Macintyre; N Brousse; N Cerf-Bensussan
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

9.  Successful infliximab treatment for steroid-refractory celiac disease: a case report.

Authors:  Helen R Gillett; Ian D R Arnott; Margaret McIntyre; Simon Campbell; Anna Dahele; Matthew Priest; Robert Jackson; Subrata Ghosh
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

Review 10.  Adult celiac disease and the severe "flat" small bowel biopsy lesion.

Authors:  Hugh James Freeman
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

View more
  13 in total

1.  Collagenous sprue: a distinctive and heterogeneous clinicopathologic disorder.

Authors:  Hugh James Freeman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-06

2.  Collagenous sprue: a case report and literature review.

Authors:  Zuoliang Xiao; Vijaya M Dasari; Donald F Kirby; Mary Bronner; Thomas P Plesec; Bret A Lashner
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-06

3.  Adult celiac disease in the elderly.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

4.  Update on collagenous sprue.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

Review 5.  Collagenous sprue.

Authors:  Hugh James Freeman
Journal:  Can J Gastroenterol       Date:  2011-04       Impact factor: 3.522

6.  Adult celiac disease and its malignant complications.

Authors:  Hugh J Freeman
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

Review 7.  Celiac disease: a disorder emerging from antiquity, its evolving classification and risk, and potential new treatment paradigms.

Authors:  Hugh J Freeman
Journal:  Gut Liver       Date:  2015-01       Impact factor: 4.519

8.  Celiac disease with a mixed pattern: a case report.

Authors:  Yalcin Basaran; Ismail Simsek; Armagan Gunal
Journal:  Cases J       Date:  2009-12-16

Review 9.  The clinical response to gluten challenge: a review of the literature.

Authors:  Maaike J Bruins
Journal:  Nutrients       Date:  2013-11-19       Impact factor: 5.717

Review 10.  Cryptogenic multifocal ulcerous stenosing enteritis: a review of the literature.

Authors:  Darina Kohoutová; Jolana Bártová; Ilja Tachecí; Stanislav Rejchrt; Rudolf Repák; Marcela Kopáčová; Jan Bureš
Journal:  Gastroenterol Res Pract       Date:  2013-11-24       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.